Proxsys Rx, LLC announces technology partnership with Catavolt, Inc. to benefit patients and health care providers

BIRMINGHAM, Ala., May 19, 2015 /PRNewswire/ -- Proxsys Rx, LLC has partnered with world-class mobile technology developer Catavolt, Inc.  to help hospitals integrate outpatient pharmacy into the continuum of care, benefiting patients and health care providers by developing a bedside discharge delivery application that resides on a handheld tablet.  Proxsys Rx provides hospitals with integrated on-site outpatient pharmacies which reduce readmissions, improve patient satisfaction and positively impact reimbursement rates for hospitals and health systems. Catavolt, Inc. is a leading provider of enterprise application mobility solutions.

Proxsys Rx provides hospitals and health care systems with an immediate financial benefit by acquiring, capitalizing and /or building outpatient pharmacies and assuming all operating and management costs. Patients can have their prescription drug prescriptions filled bedside without having to visit a pharmacy on their way home, and they can interact directly with the pharmacist via mobile device from their bedside.

"The design of the patient interface is critical to success; our partnership with Catavolt enabled us to create a platform that's efficient and easy to use. By deploying this new technology bedside, we have the opportunity to improve patient health by simplifying the discharge process for both the patient and the hospital. The results are healthier patients, better population health management, lower readmission rates because of better adherence to their doctor prescribed drug regimen, greater patient satisfaction and in turn, better reimbursement rates for the hospital," said  Marc Calhoun, Proxsys Rx Chief Strategy Officer, Enterprise Solutions.

Security of sensitive healthcare data is a priority, and Calhoun cited Catavolt's expertise in customizing proprietary security protocols as a key attribute in selecting Catavolt as technology partner. Catavolt is recognized for providing unique, patented security architecture that provides superior risk mitigation when compared to competing mobile application development, deployment and management approaches.  

"Proxsys Rx charged us with keeping patient data readily accessible in real-time, while ensuring it is secure and protected and not exposed to the Internet. Meeting that challenge helps us enable Proxsys Rx to deliver exceptional patient care", said Catavolt, Inc. Chief Executive Officer George Mashini.  The Catavolt technology will be deployed throughout the Proxsys Rx Integrated Outpatient Pharmacy Provider network.

About Proxsys Rx, LLC
Proxsys Rx, LLC is the nation's largest Integrated Outpatient Pharmacy Provider, IOPP, a health services company focused on managing and integrating outpatient pharmacies into the continuum of care for hospitals and health systems in order to enhance the quality of care and drive economic indicators. Proxsys Rx capitalizes outpatient pharmacies and provides ongoing operational support, integrating the pharmacy into high value points along the continuum of care. Proxsys Rx provides health care systems with long-term cost savings by reducing readmissions, improving HCAHPS scores and improving other key health system strategic indicators that impact reimbursements and margins and accelerate Meaningful Use compliance. Additional information is available at

About Catavolt, Inc.
Catavolt's enterprise application mobility platform helps organizations deliver real-time data to employees using mobile apps that drive operational excellence. Catavolt helps companies quickly create apps that are fast and personalized for users, secure and manageable for IT, and create meaningful outcomes for the business in 60 days or less at a fraction of the cost of traditional development approaches. For more information, visit

Media Contact: Melanie McCraney , McCraney Communications for Proxsys Rx [email protected] (205)870-8652

To view the original version on PR Newswire, visit:

SOURCE Proxsys Rx